Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases
Journal of Medicinal Chemistry · 09.07.2026 · 69 (13) · 15685-15701
DOI: 10.1021/acs.jmedchem.6c00828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.06.2026. Verfasst von Xi-Wei Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Interleukin-1 Receptor-Associated Kinases, Inflammation, Anti-Inflammatory Agents. Die Arbeit nennt 37 Literaturangaben. Gefördert von: ApicHope Pharmaceutical Group Co., Ltd..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
- ApicHope Pharmaceutical Group Co, Ltd., Guangzhou 510000, China.
- State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
- Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Guangzhou 510006, China.
ORCID-Profile: Xi-Wei Wu, Lin-Kun An
Förderung
- ApicHope Pharmaceutical Group Co., Ltd.
Zitieren
APA
Wu, X. W., Chen, Z. M., Gao, C., Tian, M., Liu, X. L., Wang, H., Chen, H. J., Li, H. X., Yang, W. Q., & An, L. K. (2026). Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry, 69(13), 15685-15701. https://doi.org/10.1021/acs.jmedchem.6c00828
Vancouver
Wu XW, Chen ZM, Gao C, Tian M, Liu XL, Wang H, et al. Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry. 2026;69(13):15685-15701. doi:10.1021/acs.jmedchem.6c00828
BibTeX
@article{Wu2026,
author = {Wu, Xi-Wei and Chen, Zhao-Min and Gao, Cui and Tian, Mi and Liu, Xi-Le and Wang, Hui and Chen, Hai-Jie and Li, Han-Xiong and Yang, Wen-Qian and An, Lin-Kun},
title = {Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {13},
pages = {15685--15701},
doi = {10.1021/acs.jmedchem.6c00828}
}
EUVIMED